Med Life (Romania) Performance

M Stock   5.88  0.07  1.20%   
The company secures a Beta (Market Risk) of -0.32, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Med Life are expected to decrease at a much lower rate. During the bear market, Med Life is likely to outperform the market. At this point, Med Life SA has a negative expected return of -0.0407%. Please make sure to verify Med Life's treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Med Life SA performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Med Life SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Med Life is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
  

Med Life Relative Risk vs. Return Landscape

If you would invest  612.00  in Med Life SA on September 30, 2024 and sell it today you would lose (24.00) from holding Med Life SA or give up 3.92% of portfolio value over 90 days. Med Life SA is currently does not generate positive expected returns and assumes 2.1568% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than Med, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Med Life is expected to under-perform the market. In addition to that, the company is 2.69 times more volatile than its market benchmark. It trades about -0.02 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.03 per unit of volatility.

Med Life Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Med Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Med Life SA, and traders can use it to determine the average amount a Med Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0189

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsM

Estimated Market Risk

 2.16
  actual daily
19
81% of assets are more volatile

Expected Return

 -0.04
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average Med Life is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Med Life by adding Med Life to a well-diversified portfolio.

About Med Life Performance

By examining Med Life's fundamental ratios, stakeholders can obtain critical insights into Med Life's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Med Life is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.

Things to note about Med Life SA performance evaluation

Checking the ongoing alerts about Med Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Med Life SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Med Life SA generated a negative expected return over the last 90 days
Evaluating Med Life's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Med Life's stock performance include:
  • Analyzing Med Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Med Life's stock is overvalued or undervalued compared to its peers.
  • Examining Med Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Med Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Med Life's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Med Life's stock. These opinions can provide insight into Med Life's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Med Life's stock performance is not an exact science, and many factors can impact Med Life's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Other Information on Investing in Med Stock

Med Life financial ratios help investors to determine whether Med Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Med with respect to the benefits of owning Med Life security.